Eikon Therapeutics, Inc. Common Stock EIKN
$10.83
-1.19%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (5 Buy · 0 Hold · 1 Sell)
- Average Price Target
- $25.00
- Implied Upside
- +130.8%
- Price Target Range
- $4.00 – $34.00
- Analysts (12 mo)
- 6
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-14 | WedbushRobert Driscoll |
Maintains | Underperform | $5 → $4 |
| 2026-05-12 | WedbushRobert Driscoll |
Maintains | Underperform | $7 → $5 |
| 2026-03-31 | WedbushRobert Driscoll |
Reiterates | Underperform | $7 |
| 2026-03-02 | Cantor FitzgeraldImogen Mansfield |
Initiates coverage on | Overweight | — |
| 2026-03-02 | JP MorganBrian Cheng |
Initiates coverage on | Overweight | $29 |
| 2026-03-02 | B of A SecuritiesJason Zemansky |
Initiates coverage on | Buy | $34 |
| 2026-03-02 | MizuhoJoseph Catanzaro |
Initiates coverage on | Outperform | $26 |
| 2026-03-02 | Morgan StanleySean Laaman |
Initiates coverage on | Overweight | $32 |
| 2026-02-26 | WedbushRobert Driscoll |
Initiates coverage on | Underperform | $7 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $10.83
- Market Cap
- $593.65 million
- 52-Week Range
- $7.90 – $17.40
- Average Volume
- 423K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.